Concepedia

γδ T cells in hepatocellular carcinoma patients present cytotoxic activity but are reduced in potency due to IL-2 and IL-21 pathways

Hang Jiang, Yang Zhao, Zhenyu Song, Mark Green, Haihan Song, Qinghua Shao

International Immunopharmacology · 2019 · 30 citations · 17 references

DOI

Concepts

References

17

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Anthony B. El-Khoueiry, Bruno Sangro, Thomas Yau et al. · The Lancet · 2017 · 4.3K citations · Full text

, , +13

IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis

Seth B. Coffelt, Kelly Kersten, Chris W. Doornebal et al. · Nature · 2015 · 1.7K citations · Full text

, , +14

Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma

Joon Hyeok Lee, Jeong‐Hoon Lee, Young‐Suk Lim et al. · Gastroenterology · 2015 · 508 citations · Full text

, , +17

Carriers of Inactive Hepatitis B Virus Are Still at Risk for Hepatocellular Carcinoma and Liver-Related Death

Jin–De Chen, Hwai‐I Yang, Uchenna H. Iloeje et al. · Gastroenterology · 2010 · 331 citations · Full text

, , +11

Phosphostim-Activated γδ T Cells Kill Autologous Metastatic Renal Cell Carcinoma

Emilie Viey, Gaëlle Fromont, Bernard Escudier et al. · The Journal of Immunology · 2005 · 182 citations · Full text

, , +17